Predictors of difficulty when discontinuing postmenopausal hormone therapy.
about
Differences in menopausal hormone therapy use among women in Germany between 1998 and 2003Compounded non-FDA-approved menopausal hormone therapy prescriptions have increased: results of a pharmacy surveyHormone therapy after the Women's Health Initiative: a qualitative study.Factors associated with successful discontinuation of hormone therapy.Hormone therapy discontinuation: physician practices after the Women's Health Initiative.The impact of comorbidities on hormone use. After the 2000 release of the Women's Health Initiative.Hormone therapy and fatal breast cancer.Attitudes and practices of gynecologists in Jaipur toward management of menopauseSleep problems after short-term hormone therapy suspension: secondary analysis of a randomized trial.Role of the nonhuman primate for research related to women's health.Relapse of vasomotor symptoms after discontinuation of the selective serotonin reuptake inhibitor escitalopram: results from the menopause strategies: finding lasting answers for symptoms and health research network.Menopausal symptom experience before and after stopping estrogen therapy in the Women's Health Initiative randomized, placebo-controlled trial.Ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy: potential benefits in bone and breast.Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.Tapering versus cold turkey: symptoms versus successful discontinuation of menopausal hormone therapy.Progesterone for hot flush and night sweat treatment--effectiveness for severe vasomotor symptoms and lack of withdrawal rebound.Reasons why women in Turkey prefer short-term use of hormone replacement therapy (HRT).Current patient perceptions on the menopause: a South African perspective.Investigating the effects of estradiol or estradiol/progesterone treatment on mood, depressive symptoms, menopausal symptoms and subjective sleep quality in older healthy hysterectomized women: a questionnaire study.Vasomotor Symptoms Across the Menopause Transition: Differences Among Women
P2860
Q21254698-BBC21341-55DA-4464-BA88-4E56E19EDDAFQ27317641-075E0F58-5B88-4315-8B7D-D670E7132DA8Q33261267-47AB1FD8-2D6B-45E1-907A-C451FF08C0D3Q33571609-3A291AC4-F908-40F4-B038-CE88AE1F8D26Q33981720-D68C3CD7-F7B5-4B78-B4BA-0ACCC4A1C66EQ34722892-4C02AB27-2DDE-4AB8-93E2-2BB4798811C7Q34994476-5695BAFA-D560-4574-B94C-92338013D44BQ35066059-7ED2645B-B7CB-494C-A2C8-B10CE776F4C3Q35473768-C3DA5920-34FF-431C-B2EE-1543C32685A5Q35757584-258BB169-A268-46AB-B001-9434BDB44A96Q36579331-A45D4558-3642-424D-A877-B925F46DDDB5Q37163204-8A77E2F1-513E-4E30-9328-6F43302DD312Q37221035-FF936849-C74A-4E62-A4C4-080387CE9424Q42167610-5E5578C3-2D16-4133-9975-02BC6777DD44Q42578843-104BFD77-7EB2-4DC0-9E62-3AAF9D8690E3Q44750448-861519E5-6F75-4C73-ADC4-3BC5C727150AQ45242556-C37ED540-5989-4B52-B5A9-845CD129EB0AQ46149673-01480DB1-C2E5-444B-8A29-080E32AB839CQ46533689-AAB07C43-C420-48FA-A339-FEF3E214CBB3Q58551831-EBA5BF76-5912-4CE3-82D4-F2E3A59A658E
P2860
Predictors of difficulty when discontinuing postmenopausal hormone therapy.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Predictors of difficulty when discontinuing postmenopausal hormone therapy.
@en
type
label
Predictors of difficulty when discontinuing postmenopausal hormone therapy.
@en
prefLabel
Predictors of difficulty when discontinuing postmenopausal hormone therapy.
@en
P2093
P1476
Predictors of difficulty when discontinuing postmenopausal hormone therapy.
@en
P2093
Alice Pressman
Anna N A Tosteson
Bruce Ettinger
Deborah Grady
Judith L Macer
P304
P356
10.1016/J.OBSTETGYNECOL.2003.09.025
P407
P577
2003-12-01T00:00:00Z